Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
pfizer
3
×
san diego blog main
san diego top stories
biotech
boston blog main
boston top stories
new york blog main
new york top stories
san francisco blog main
startups
abiraterone
ac immune
acorda therapeutics
acute myeloid leukemia
aduro biotech
adverum biotechnologies
agenus
akcea therapeutics
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
ambit biosciences
anylam pharmaceuticals
apalutamide
athena countouriotis
atypical hemolytic uremic syndrome
bill cassidy
biogen
boulder/denver blog main
boulder/denver top stories
brett zbar
bristol-myers squibb
caelum biosciences
cancer
cancer immunotherapy
cardiomyopathy
What
drug
year
3
×
ago
akcea
alnylam
alzheimer’s
amyloidosis
approved
athena
attr
available
battle
bio
biotech
cancer
ceo
chief
companies
countouriotis
debilitating
different
disease
fail
fda
financing
gene
genetic
gets
increases
latest
medical
medicines
mezzanine
million
names
new
officer
oks
old
patients
Language
Current search:
year
×
pfizer
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push